Viruses
Page 3: General Properties of Viruses
Characteristics of Viruses and Viroids
Nonliving particles that require living cells for reproduction
Composed of nucleic acid genomes
Tobacco Mosaic Virus (TMV) noted as the first virus discovered
Figure 19.1: Affected plant with TMV
Page 4: Hosts and Characteristics of Selected Viruses
Table 19.1 Overview
Virus or Group: Identifies various viruses and their characteristics.
Nucleic Acid Type: dsDNA or ssRNA
Genome Size: Expressed in kb (kilobases)
Example Viruses:
Phage (E. coli): Lytic or harmless in host
Tobacco Mosaic Virus (TMV): Causes leaf mottling
Herpes Simplex: Causes blisters
Effect on Host: Ranges from harmless to severe effects
Page 5: Properties of Viruses
Basic Structure and Diversity
Viruses are small infectious particles with nucleic acid and a protein coat
Over 4,000 different types exist
Variation in host ranges, structures, and genome compositions
Page 6: Differences Among Viruses
Key Differences
Host Range: Different species and cell types affected
Structural Features:
All have capsids, varying in shape
Envelopes derived from host membranes
Genome Variations:
DNA vs. RNA, single vs. double stranded, linear vs. circular
Examples of viruses affecting various body systems
Page 7: Viral Structures
Types of Virus Structures
Images illustrate structures:
a) Tobacco mosaic virus (helical, nonenveloped)
b) Adenovirus (polyhedral, nonenveloped)
c) Influenza virus (enveloped)
d) T4 bacteriophage (complex structure)
Page 9: Reproduction of Viruses
Nature of Viruses
Viruses are not considered alive
Not composed of cells
Unable to perform metabolism independently
Viral reproductive cycles vary among virus types
Page 10: Viral Reproductive Cycle
Steps in Reproduction
Attachment
Entry
Integration
Synthesis of Viral Components
Viral Assembly
Release
Page 11: Steps 1 and 2 - Attachment and Entry
Detailed Description
Attachment: Specific binding to cell surface molecules
Entry:
Bacteriophage: Injects DNA
HIV: Fusion with host membrane
Immediate expression of viral genes possible
Page 12: Step 3 - Integration
Integration Process
Viral gene for integrase facilitates integration
Prophage: Integration into bacterial DNA
HIV: Uses reverse transcriptase to convert RNA to DNA
Page 13: Step 4 - Synthesis of Viral Components
Synthesis Details
Host enzymes replicate phage DNA and transcribe genes to mRNA
In HIV: DNA is transcribed in the nucleus to produce viral RNA
Page 14: Steps 5 and 6 - Assembly and Release
Assembly Overview
Some viruses self-assemble; others require additional proteins
Release Mechanisms:
Phages lyse host cells
Enveloped viruses bud off from cells
Page 15: Latency in Bacteriophages
Latent Phases
Integration of viral genomes leads to inactive/prophage states
Host cell replication includes prophage
Lytic vs. Lysogenic Cycle: Understanding the differences
Page 16: Prophage Dynamics
Lifecycle Description
Overview of lytic and lysogenic cycles including infection and release mechanisms
Page 17: Latency in Human Viruses
Mechanisms of Latency
Virus integration into host genome can lead to dormancy
Examples: HIV, herpes simplex viruses
Page 18: Emerging Viruses
Characteristics of Emerging Viruses
Recently arisen or increased infectiousness
Typically results from mutations in existing viruses
Examples: Coronavirus, H1N1, Zika, HIV
Page 19: Overview of COVID-19
Coronavirus Information
SARS-CoV-2 causes COVID-19, identified as a pandemic
Symptoms include fever, cough, pneumonia
Statistics on global COVID-19 cases and deaths
Page 20: HIV and AIDS
Disease Transmission
Modes of HIV transmission: sexual contact, blood transfusion, mother to child
Page 21: AIDS Statistics
Key Data Points
Total AIDS-related deaths since 1981
Prevalence and incidence data for HIV
Page 22: Impact of AIDS on the Immune System
Effects on Immunity
Destruction of helper T cells significantly impacts immune function
Increased susceptibility to opportunistic infections
Page 23: Drugs for HIV
Treatment Advances
Decrease in AIDS-related death rates
New antiviral drugs inhibit virus proliferation
Page 24: Drug Strategies for HIV
Approach to Treatment
Binding virus proteins and blocking necessary proteases
Challenges: Avoiding binding to host proteins
Utilizing drug cocktails to reduce resistance